drugset / Trial / NCT01476930

Cupping and Serkangabin Versus Conventional Migraine Treatment

NCT01476930

Phase 4 Completed 391 enrolled Birjand University of Medical Sciences
RandomizedParallel-groupOpen-labelTreatment

Summary

Migraine is the most common recurrent headache. Current therapy of migraine headache consists of multiple drug groups for control of attack and prophylaxis against recurrent attacks. Emerging alternative medicine worldwide led investigators to evaluate the efficacy of cupping therapy plus SERKANGABIN syrup in treatment of migraine headache. Severity, duration and frequency of attacks of migraine headache evaluated in two groups during six months from presentation.

Timeline

Start
2008-06
Primary completion
2009-09
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nortriptyline Small molecule
Comparator Propranolol Small molecule
Comparator Sumatriptan Unknown
Comparator ergotamine Small molecule

Indications